Gastrointestinal endoscopy company Pentax Medical has obtained Health Canada license for its Pentax RetroView Colonoscope (EC-3490TLi), designed for use in diagnostic colonoscopy procedures for colorectal cancer screening and therapeutic ...
Tags: Health, Medical, meaningful clinical care
Volition has announced a new collaboration with the Wales Cancer Bank,with the two businesses set to carry out an internal clinical study for the Nucleosomics diagnostic products. At the end of this month,tests will be carried out on ...
Tags: Volition, Wales Cancer Bank, Nucleosomics diagnostic products
Exact Sciences has completed enrolling patients in its DeeP-C pivotal trial, designed to compare the accuracy of the stool DNA test in screening colorectal cancer with traditional screening methods. The test uses stool samples collected ...
Tags: Exact Sciences, DeeP-C pivotal trial, colorectal cancer
Enzo Biochem's Clinical Labs has launched a new diagnostic test, designed to assess and detect lung cancer at earlier stages, in New York metropolitan market as well as New Jersey and Eastern Pennsylvania, US. Using a panel of tumor ...
Tags: Enzo Biochem, diagnostic test, EarlyCDT-Lung test, EarlyCDT-Lung
ConvaTec, a developer of new medical technologies, has inaugurated a new office at the World Trade Center in Bangalore, India. The new facility, which will serve as headquarters for the company's Indian operations, will offer hospitals ...
Tags: medical technologies, medical, Convatec, healthcare, New Office
Lantheus Medical Imaging will receive $300,000 Massachusetts-Israel Innovation Partnership (MIIP) grant, upon signing a collaboration agreement with Check-Cap. The grant will be used by the companies to develop and manufacture new 3-D ...
Tags: Check-Cap, 3-D Imaging Capsule, colon cancer
Molecular diagnostics company Exact Sciences has submitted to the US Food and Drug Administration(FDA)the first module of the premarket approval(PMA)application for its stool DNA colorectal cancer screening test. The first modular ...
Tags: molecular diagnostics, Exact Sciences, PMA application
Epigenomics has reported positive results from a clinical study, which showed that its blood-based colorectal cancer (CRC) detection test is non-inferior in sensitivity when compared to fecal immunochemical testing (FIT). Using patients ...
Tags: Epigenomics, blood-based colorectal cancer, non-inferior in sensitivity
NanoString Technologies has reported positive results from a second validation study of its breast cancer assay based on the PAM50 gene expression signature. The CE-marked breast cancer assay is designed to provide a subtype ...
Tags: NanoString Technologies, breast cancer assay, PAM50 gene signature, study
Qiagen has won the US Food and Drug Administration (FDA) approval for its new molecular companion diagnostic product, therascreen KRAS RGQ PCR test kit, to provide guidance on the use of Erbitux for approximately 110,000 US patients with ...
Tags: Qiagen, FDA, molecular companion diagnostic product, test kit
Bayer HealthCare has filed a new drug application (NDA) with the FDA seeking approval for the oral multi-kinase inhibitor regorafenib to treat patients with metastatic colorectal cancer (mCRC). The company has even filed an application ...
Tags: oral multi-kinase inhibitor regorafenib, metastatic colorectal cancer
Epigenomics has announced results from a comparative study between its blood-based colorectal cancer(CRC)detection test Epi proColon and fecal immunochemical testing(FIT)to demonstrate the non-inferiority of Epi proColon in detection of ...
Tags: Epigenomics, CRC, FIT, Epi proColon
Chronix Biomedical has opened a fully operational sequencing laboratory in Brookings, South Dakota, US, to expand its commercial capabilities. Chronix has opened the laboratory in association with the First Bank & Trust of Brookings, ...
Enzo Biochem, a molecular diagnostics company, has introduced the ColonSentry blood-based risk stratification test to assess a patient's risk of having colorectal cancer. ColonSentry requires a small blood sample and utilizes RNA to ...
Tags: Enzo Biochem, ColonSentry blood-based risk stratification test
Enzo Biochem has received New York State Department of Health approval for ColonSentry RNA expression assay to assess colorectal cancer risk. The ColonSentry test requires only a small blood sample and can thus be easily incorporated as a ...
Tags: Enzo Biochem, ColonSentry test, ColonSentry RNA expression assay